Compare OSIS & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OSIS | BLLN |
|---|---|---|
| Founded | 1987 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.4B |
| IPO Year | 1997 | 2025 |
| Metric | OSIS | BLLN |
|---|---|---|
| Price | $197.16 | $106.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 9 |
| Target Price | ★ $278.29 | $123.75 |
| AVG Volume (30 Days) | 180.3K | ★ 486.0K |
| Earning Date | 10-29-2026 | 08-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 2.76 | ★ 103.40 |
| EPS | ★ 8.95 | 0.48 |
| Revenue | ★ $1,089,286,000.00 | $305,112,000.00 |
| Revenue This Year | $6.84 | $49.16 |
| Revenue Next Year | $6.42 | $26.40 |
| P/E Ratio | ★ $21.46 | $241.80 |
| Revenue Growth | 13.35 | ★ 99.97 |
| 52 Week Low | $186.50 | $61.96 |
| 52 Week High | $311.72 | $150.44 |
| Indicator | OSIS | BLLN |
|---|---|---|
| Relative Strength Index (RSI) | 37.08 | 48.66 |
| Support Level | $186.50 | $79.07 |
| Resistance Level | $206.19 | $108.50 |
| Average True Range (ATR) | 5.55 | 7.02 |
| MACD | -0.12 | 0.37 |
| Stochastic Oscillator | 25.42 | 30.57 |
OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems, and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. The majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East and Africa, and the Asia Pacific regions.
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.